Publications

• Spaceflight alters protein levels and gene expression associated with stress response and metabolic characteristics in human cardiac spheroids.
  Biomaterials Volume: 317 Page(s): 123080
  06/01/2025 Authors: Forghani P; Liu W; Wang Z; Ling Z; Takaesu F; Yang E; Tharp GK; Nielsen S; Doraisingam S; Countryman S
• The mitochondrial citrate carrier SLC25A1 regulates metabolic reprogramming and morphogenesis in the developing heart.
  Commun Biol Volume: 7 Page(s): 1422
  10/31/2024 Authors: Ohanele C; Peoples JN; Karlstaedt A; Geiger JT; Gayle AD; Ghazal N; Sohani F; Brown ME; Davis ME; Porter GA
• Differential Effects of Four Canonical Notch-Activating Ligands on c-Kit+ Cardiac Progenitor Cells.
  Int J Mol Sci Volume: 25
  10/17/2024 Authors: Robeson M; Goudy SL; Davis ME
• Investigation of a chronic single-stage sheep Fontan model.
  JTCVS Open Volume: 21 Page(s): 268 - 278
  10/01/2024 Authors: Kelly JM; Hu Z; Takaesu F; Watanabe T; Storrs J; Blais B; Yuhara S; Morrison A; Nelson K; Ulziibayar A
• Myocardial Matrix Hydrogels Mitigate Negative Remodeling and Improve Function in Right HeartFailure Model.
  JACC Basic Transl Sci Volume: 9 Page(s): 322 - 338
  03/01/2024 Authors: Hunter JD; Mesfin JM; Ahmed T; Chen A; Reimold K; Hancko A; Braden RL; Davis ME; Christman KL
• Characterization of decellularized left and right ventricular myocardial matrix hydrogels and their effects on cardiac progenitor cells.
  J Mol Cell Cardiol Volume: 171 Page(s): 45 - 55
  10/01/2022 Authors: Hunter JD; Hancko A; Shakya P; Hill R; Saviola AJ; Hansen KC; Davis ME; Christman KL
• Autologous Cardiac Stem Cell Injection in Patients with Hypoplastic Left Heart Syndrome (CHILD Study).
  Pediatr Cardiol Volume: 43 Page(s): 1481 - 1493
  10/01/2022 Authors: Kaushal S; Hare JM; Shah AM; Pietris NP; Bettencourt JL; Piller LB; Khan A; Snyder A; Boyd RM; Abdullah M
• Comparative efficacy and mechanism of action of cardiac progenitor cells after cardiac injury.
  iScience Volume: 25 Page(s): 104656
  08/19/2022 Authors: Gunasekaran M; Mishra R; Saha P; Morales D; Cheng W-C; Jayaraman AR; Hoffman JR; Davidson L; Chen L; Shah AM
• Engineering Cardiac Small Extracellular Vesicle-Derived Vehicles with Thin-Film Hydration for Customized microRNA Loading.
  J Cardiovasc Dev Dis Volume: 8
  10/22/2021 Authors: Bheri S; Kassouf BP; Park H-J; Hoffman JR; Davis ME
• Age and pre quit-day attrition during smoking cessation treatment.
  Cogn Behav Ther Volume: 49 Page(s): 361 - 373
  09/01/2020 Authors: Conroy HE; Jacquart J; Baird SO; Rosenfield D; Davis ML; Powers MB; Frierson GM; Marcus BH; Otto MW; Zvolensky MJ
• Endogenous testosterone levels are predictive of symptom reduction with exposure therapy in social anxiety disorder.
  Psychoneuroendocrinology Volume: 115 Page(s): 104612
  05/01/2020 Authors: Hutschemaekers MHM; de Kleine RA; Davis ML; Kampman M; Smits JAJ; Roelofs K
• Efficacy of digital cognitive behavioural therapy for symptoms of generalised anxiety disorder: a study protocol for a randomised controlled trial.
  Trials Volume: 21 Page(s): 357
  04/23/2020 Authors: Gu J; Miller CB; Henry AL; Espie CA; Davis ML; Stott R; Emsley R; Smits JAJ; Craske M; Saunders KEA
• Clinicians' perspectives of interfering behaviors in the treatment of anxiety and obsessive-compulsive disorders in adults and children.
  Cogn Behav Ther Volume: 49 Page(s): 81 - 96
  01/01/2020 Authors: Davis ML; Fletcher T; McIngvale E; Cepeda SL; Schneider SC; La Buissonnire Ariza V; Egberts J; Goodman W; Storch EA
• Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis.
  J Anxiety Disord Volume: 68 Page(s): 102149
  12/01/2019 Authors: Rosenfield D; Smits JAJ; Hofmann SG; Mataix-Cols D; de la Cruz LF; Andersson E; Rck C; Monzani B; Prez-Vigil A; Frumento P
• Re: "Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial" by Findling et al. (J Child Adolesc Psychopharmacol 2019;29:80-89).
  J Child Adolesc Psychopharmacol Volume: 29 Page(s): 725
  11/01/2019 Authors: Mosholder AD; Kim J; Davis M; Farchione TR
• In vivo evidence for dysregulation of mGluR5 as a biomarker of suicidal ideation.
  Proc Natl Acad Sci U S A Volume: 116 Page(s): 11490 - 11495
  06/04/2019 Authors: Davis MT; Hillmer A; Holmes SE; Pietrzak RH; DellaGioia N; Nabulsi N; Matuskey D; Angarita G; Carson RE; Krystal JH
• Lower synaptic density is associated with depression severity and network alterations.
  Nat Commun Volume: 10 Page(s): 1529
  04/04/2019 Authors: Holmes SE; Scheinost D; Finnema SJ; Naganawa M; Davis MT; DellaGioia N; Nabulsi N; Matuskey D; Angarita GA; Pietrzak RH
• Challenges in Research on Suicide Prevention.
  JAMA Volume: 321 Page(s): 1104 - 1105
  03/19/2019 Authors: Kim J; Davis M; Farchione T
• Subthreshold Fear Conditioning Produces a Rapidly Developing Neural Mechanism that Primes Subsequent Learning.
  eNeuro Volume: 6
  01/01/2019 Authors: Cole KE; Lee J; Davis M; Parsons RG
• A Bioprinted Cardiac Patch Composed of Cardiac-Specific Extracellular Matrix and Progenitor Cells for Heart Repair.
  Adv Healthc Mater Volume: 7 Page(s): e1800672
  12/01/2018 Authors: Bejleri D; Streeter BW; Nachlas ALY; Brown ME; Gaetani R; Christman KL; Davis ME
• Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins.
  JAMA Dermatol Volume: 154 Page(s): 1401 - 1408
  12/01/2018 Authors: Kim CC; Berry EG; Marchetti MA; Swetter SM; Lim G; Grossman D; Curiel-Lewandrowski C; Chu EY; Ming ME; Zhu K
• Does exercise aid smoking cessation through reductions in anxiety sensitivity and dysphoria?
  Health Psychol Volume: 37 Page(s): 647 - 657
  07/01/2018 Authors: Zvolensky MJ; Rosenfield D; Garey L; Kauffman BY; Langdon KJ; Powers MB; Otto MW; Davis ML; Marcus BH; Church TS
• Impact of the 2016 US presidential election on OCD symptom presentation: A case illustration.
  J Clin Psychol Volume: 74 Page(s): 750 - 754
  05/01/2018 Authors: Davis ML; McCann M; Goodman WK; Storch EA
• Controlled JAGGED1 delivery induces human embryonic palate mesenchymal cells to form osteoblasts.
  J Biomed Mater Res A Volume: 106 Page(s): 552 - 560
  02/01/2018 Authors: Ndong JDLC; Stephenson Y; Davis ME; Garca AJ; Goudy S
• A Concise Review of the Conflicting Roles of Dopamine-1 versus Dopamine-2 Receptors in Wound Healing.
  Molecules Volume: 23
  12/26/2017 Authors: Vaughn AR; Davis MJ; Sivamani RK; Isseroff RR
• A randomized controlled study of power posing before public speaking exposure for social anxiety disorder: No evidence for augmentative effects.
  J Anxiety Disord Volume: 52 Page(s): 1 - 7
  12/01/2017 Authors: Davis ML; Papini S; Rosenfield D; Roelofs K; Kolb S; Powers MB; Smits JAJ
• Developing a Clinically Relevant Tissue Engineered Heart Valve-A Review of Current Approaches.
  Adv Healthc Mater Volume: 6
  12/01/2017 Authors: Nachlas ALY; Li S; Davis ME
• Massive perianal ulceration: Entamoeba histolytica and Candida albicans co-infection.
  JAAD Case Rep Volume: 3 Page(s): 553 - 555
  11/01/2017 Authors: Davis MJ; Templeton SF; Dickensheets DL; Gross AS
• Altered metabotropic glutamate receptor 5 markers in PTSD: In vivo and postmortem evidence.
  Proc Natl Acad Sci U S A Volume: 114 Page(s): 8390 - 8395
  08/01/2017 Authors: Holmes SE; Girgenti MJ; Davis MT; Pietrzak RH; DellaGioia N; Nabulsi N; Matuskey D; Southwick S; Duman RS; Carson RE
• D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.
  JAMA Psychiatry Volume: 74 Page(s): 501 - 510
  05/01/2017 Authors: Mataix-Cols D; Fernndez de la Cruz L; Monzani B; Rosenfield D; Andersson E; Prez-Vigil A; Frumento P; de Kleine RA; Difede J; Dunlop BW
• Identifying attendance patterns in a smoking cessation treatment and their relationships with quit success.
  Drug Alcohol Depend Volume: 174 Page(s): 65 - 69
  05/01/2017 Authors: Jacquart J; Papini S; Davis ML; Rosenfield D; Powers MB; Frierson GM; Hopkins LB; Baird SO; Marcus BH; Church TS
• Mitigating effect of EUK-207 on radiation-induced cognitive impairments.
  Behav Brain Res Volume: 320 Page(s): 457 - 463
  03/01/2017 Authors: Raber J; Davis MJ; Pfankuch T; Rosenthal R; Doctrow SR; Moulder JE
• Low startle magnitude may be a behavioral marker of vulnerability to cocaine addiction.
  Synapse Volume: 71 Page(s): 46 - 50
  01/01/2017 Authors: Wheeler MG; Duncan E; Davis M
• Mechanisms underlying long-term fear memory formation from a metaplastic neuronal state.
  Neurobiol Learn Mem Volume: 136 Page(s): 47 - 53
  12/01/2016 Authors: Parsons RG; Walker DL; Davis M
• Attention bias dynamics and symptom severity during and following CBT for social anxiety disorder.
  J Consult Clin Psychol Volume: 84 Page(s): 795 - 802
  09/01/2016 Authors: Davis ML; Rosenfield D; Bernstein A; Zvielli A; Reinecke A; Beevers CG; Koster EHW; Smits JAJ
• Baseline psychophysiological and cortisol reactivity as a predictor of PTSD treatment outcome in virtual reality exposure therapy.
  Behav Res Ther Volume: 82 Page(s): 28 - 37
  07/01/2016 Authors: Norrholm SD; Jovanovic T; Gerardi M; Breazeale KG; Price M; Davis M; Duncan E; Ressler KJ; Bradley B; Rizzo A
• Emotion dysregulation explains relations between sleep disturbance and smoking quit-related cognition and behavior.
  Addict Behav Volume: 57 Page(s): 6 - 12
  06/01/2016 Authors: Fillo J; Alfano CA; Paulus DJ; Smits JAJ; Davis ML; Rosenfield D; Marcus BH; Church TS; Powers MB; Otto MW
• The Efficacy of Vigorous-Intensity Exercise as an Aid to Smoking Cessation in Adults With High Anxiety Sensitivity: A Randomized Controlled Trial.
  Psychosom Med Volume: 78 Page(s): 354 - 364
  04/01/2016 Authors: Smits JAJ; Zvolensky MJ; Davis ML; Rosenfield D; Marcus BH; Church TS; Powers MB; Frierson GM; Otto MW; Hopkins LB
• Effects of Proton and Combined Proton and (56)Fe Radiation on the Hippocampus.
  Radiat Res Volume: 185 Page(s): 20 - 30
  01/01/2016 Authors: Raber J; Allen AR; Sharma S; Allen B; Rosi S; Olsen RHJ; Davis MJ; Eiwaz M; Fike JR; Nelson GA
• Bioactive nanoparticles improve calcium handling in failing cardiac myocytes.
  Nanomedicine (Lond) Volume: 10 Page(s): 3343 - 3357
  11/01/2015 Authors: Maxwell JT; Somasuntharam I; Gray WD; Shen M; Singer JM; Wang B; Saafir T; Crawford BH; Jiang R; Murthy N
• Intramyocardial Delivery of Notch Ligand-Containing Hydrogels Improves Cardiac Function and Angiogenesis Following Infarction.
  Tissue Eng Part A Volume: 21 Page(s): 2315 - 2322
  09/01/2015 Authors: Boopathy AV; Martinez MD; Smith AW; Brown ME; Garca AJ; Davis ME
• Behavioral therapies for treatment-seeking cannabis users: a meta-analysis of randomized controlled trials.
  Eval Health Prof Volume: 38 Page(s): 94 - 114
  03/01/2015 Authors: Davis ML; Powers MB; Handelsman P; Medina JL; Zvolensky M; Smits JAJ
• A meta-analysis of the efficacy of acceptance and commitment therapy for clinically relevant mental and physical health problems.
  Psychother Psychosom Volume: 84 Page(s): 30 - 36
  01/01/2015 Authors: A-Tjak JGL; Davis ML; Morina N; Powers MB; Smits JAJ; Emmelkamp PMG
• Psychophysiological and Cortisol Reactivity Predicts PTSD Treatment Outcome in Virtual Reality Exposure Therapy with D-Cycloserine
  Volume: 39 Page(s): S369 - S370
  12/01/2014 Authors: Jovanovic T; Norrholm S; Gerardi M; Breazeale K; Davis M; Duncan E; Ressler K; Bradley B; Rizzo A; Rothbaum B
• Update on the efficacy of pharmacotherapy for social anxiety disorder: a meta-analysis.
  Expert Opin Pharmacother Volume: 15 Page(s): 2281 - 2291
  11/01/2014 Authors: Davis ML; Smits JAJ; Hofmann SG
• Cultured human bone marrow-derived CD31(+) cells are effective for cardiac and vascular repair through enhanced angiogenic, adhesion, and anti-inflammatory effects.
  J Am Coll Cardiol Volume: 64 Page(s): 1681 - 1694
  10/21/2014 Authors: Kim S-W; Houge M; Brown M; Davis ME; Yoon Y-S
• Characterization of the novel positive allosteric modulator of the metabotropic glutamate receptor 4 ADX88178 in rodent models of neuropsychiatric disorders.
  J Pharmacol Exp Ther Volume: 350 Page(s): 495 - 505
  09/01/2014 Authors: Kalinichev M; Le Poul E; Bola C; Girard F; Campo B; Fonsi M; Royer-Urios I; Browne SE; Uslaner JM; Davis MJ
• Cognitive-behavioral therapy for hypochondriasis/health anxiety: a meta-analysis of treatment outcome and moderators.
  Behav Res Ther Volume: 58 Page(s): 65 - 74
  07/01/2014 Authors: Olatunji BO; Kauffman BY; Meltzer S; Davis ML; Smits JAJ; Powers MB
• A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans.
  Am J Psychiatry Volume: 171 Page(s): 640 - 648
  06/01/2014 Authors: Rothbaum BO; Price M; Jovanovic T; Norrholm SD; Gerardi M; Dunlop B; Davis M; Bradley B; Duncan EJ; Rizzo A
• Yohimbine enhancement of exposure therapy for social anxiety disorder: a randomized controlled trial.
  Biol Psychiatry Volume: 75 Page(s): 840 - 846
  06/01/2014 Authors: Smits JAJ; Rosenfield D; Davis ML; Julian K; Handelsman PR; Otto MW; Tuerk P; Shiekh M; Rosenfield B; Hofmann SG
• Targeting extracellular DNA to deliver IGF-1 to the injured heart.
  Sci Rep Volume: 4 Page(s): 4257
  03/07/2014 Authors: Khan RS; Martinez MD; Sy JC; Pendergrass KD; Che P-L; Brown ME; Cabigas EB; Dasari M; Murthy N; Davis ME
• Neonatal lesions of orbital frontal areas 11/13 in monkeys alter goal-directed behavior but spare fear conditioning and safety signal learning.
  Front Neurosci Volume: 8 Page(s): 37
  01/01/2014 Authors: Kazama AM; Davis M; Bachevalier J
• Comparative genomics of cultured and uncultured strains suggests genes essential for free-living growth of Liberibacter.
  PLoS One Volume: 9 Page(s): e84469
  01/01/2014 Authors: Fagen JR; Leonard MT; McCullough CM; Edirisinghe JN; Henry CS; Davis MJ; Triplett EW
• Self-assembling peptide-based delivery of therapeutics for myocardial infarction.
  Volume: 1141 Page(s): 159 - 164
  01/01/2014 Authors: Boopathy AV; Davis ME
• CGRP antagonist infused into the bed nucleus of the stria terminalis impairs the acquisition and expression of context but not discretely cued fear.
  Learn Mem Volume: 20 Page(s): 730 - 739
  11/19/2013 Authors: Sink KS; Davis M; Walker DL
• Cellular encapsulation enhances cardiac repair.
  J Am Heart Assoc Volume: 2 Page(s): e000367
  10/10/2013 Authors: Levit RD; Landzuri N; Phelps EA; Brown ME; Garca AJ; Davis ME; Joseph G; Long R; Safley SA; Suever JD
• Related functions of mGlu4 and mGlu8.
  Pharmacol Biochem Behav Volume: 111 Page(s): 11 - 16
  10/01/2013 Authors: Davis MJ; Duvoisin RM; Raber J
• Delivery of Nox2-NADPH oxidase siRNA with polyketal nanoparticles for improving cardiac function following myocardial infarction.
  Biomaterials Volume: 34 Page(s): 7790 - 7798
  10/01/2013 Authors: Somasuntharam I; Boopathy AV; Khan RS; Martinez MD; Brown ME; Murthy N; Davis ME
• D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions.
  J Psychiatr Res Volume: 47 Page(s): 1455 - 1461
  10/01/2013 Authors: Smits JAJ; Rosenfield D; Otto MW; Marques L; Davis ML; Meuret AE; Simon NM; Pollack MH; Hofmann SG
• Acute preconditioning of cardiac progenitor cells with hydrogen peroxide enhances angiogenic pathways following ischemia-reperfusion injury.
  Stem Cells Dev Volume: 22 Page(s): 2414 - 2424
  09/01/2013 Authors: Pendergrass KD; Boopathy AV; Seshadri G; Maiellaro-Rafferty K; Che PL; Brown ME; Davis ME
• Inhibition of fear is differentially associated with cycling estrogen levels in women.
  J Psychiatry Neurosci Volume: 38 Page(s): 341 - 348
  09/01/2013 Authors: Glover EM; Mercer KB; Norrholm SD; Davis M; Duncan E; Bradley B; Ressler KJ; Jovanovic T
• Effects of whole body (56)Fe radiation on contextual freezing and Arc-positive cells in the dentate gyrus.
  Behav Brain Res Volume: 246 Page(s): 162 - 167
  06/01/2013 Authors: Raber J; Allen AR; Rosi S; Sharma S; Dayger C; Davis MJ; Fike JR
• Effects of (56)Fe radiation on hippocampal function in mice deficient in chemokine receptor 2 (CCR2).
  Behav Brain Res Volume: 246 Page(s): 69 - 75
  06/01/2013 Authors: Raber J; Allen AR; Rosi S; Sharma S; Dayger C; Davis MJ; Fike JR
• Induction of pluripotency in bone marrow mononuclear cells via polyketal nanoparticle-mediated delivery of mature microRNAs.
  Biomaterials Volume: 34 Page(s): 4235 - 4241
  06/01/2013 Authors: Sohn Y-D; Somasuntharam I; Che P-L; Jayswal R; Murthy N; Davis ME; Yoon Y-S
• Functionalized dendrimer-based delivery of angiotensin type 1 receptor siRNA forpreserving cardiac function following infarction.
  Biomaterials Volume: 34 Page(s): 3729 - 3736
  05/01/2013 Authors: Liu J; Gu C; Cabigas EB; Pendergrass KD; Brown ME; Luo Y; Davis ME
• Early effects of whole-body (56)Fe irradiation on hippocampal function in C57BL/6J mice.
  Radiat Res Volume: 179 Page(s): 590 - 596
  05/01/2013 Authors: Haley GE; Yeiser L; Olsen RHJ; Davis MJ; Johnson LA; Raber J
• CRF and Pacap Molecular Pathways Mediating Bnst-Dependent Behaviors: From Mice to Humans
  Volume: 73 Page(s): 25S - 25S
  05/01/2013 Authors: Ressler K; Jovanovic T; Gafford G; Sink K; Rainnie D; Davis M
• Oxidative stress-induced Notch1 signaling promotes cardiogenic gene expression in mesenchymal stem cells.
  Stem Cell Res Ther Volume: 4 Page(s): 43
  04/18/2013 Authors: Boopathy AV; Pendergrass KD; Che PL; Yoon Y-S; Davis ME
• A novel AX+/BX- paradigm to assess fear learning and safety-signal processing with repeated-measure designs.
  J Neurosci Methods Volume: 214 Page(s): 177 - 183
  04/15/2013 Authors: Kazama AM; Schauder KB; McKinnon M; Bachevalier J; Davis M
• Anxiogenic effects of CGRP within the BNST may be mediated by CRF acting at BNST CRFR1 receptors.
  Behav Brain Res Volume: 243 Page(s): 286 - 293
  04/15/2013 Authors: Sink KS; Chung A; Ressler KJ; Davis M; Walker DL
• Acute stress disorder versus chronic posttraumatic stress disorder: inhibition of fear as a function of time since trauma.
  Depress Anxiety Volume: 30 Page(s): 217 - 224
  03/01/2013 Authors: Jovanovic T; Sakoman AJ; Kozari-Kovai D; Metrovi AH; Duncan EJ; Davis M; Norrholm SD
• Mapping of the mouse olfactory system with manganese-enhanced magnetic resonance imaging and diffusion tensor imaging.
  Brain Struct Funct Volume: 218 Page(s): 527 - 537
  03/01/2013 Authors: Gutman DA; Magnuson M; Majeed W; Keifer OP; Davis M; Ressler KJ; Keilholz S
• Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety.
  Mol Psychiatry Volume: 18 Page(s): 308 - 319
  03/01/2013 Authors: Sink KS; Walker DL; Freeman SM; Flandreau EI; Ressler KJ; Davis M
• Role of mGluR4 in acquisition of fear learning and memory.
  Neuropharmacology Volume: 66 Page(s): 365 - 372
  03/01/2013 Authors: Davis MJ; Iancu OD; Acher FC; Stewart BM; Eiwaz MA; Duvoisin RM; Raber J
• Dendrimeric bowties featuring hemispheric-selective decoration of ligands for microRNA-based therapy.
  Biomacromolecules Volume: 14 Page(s): 101 - 109
  01/14/2013 Authors: Gray WD; Wu RJ; Yin X; Zhou J; Davis ME; Luo Y
• Cognitive-behavioral therapy for obsessive-compulsive disorder: a meta-analysis of treatment outcome and moderators.
  J Psychiatr Res Volume: 47 Page(s): 33 - 41
  01/01/2013 Authors: Olatunji BO; Davis ML; Powers MB; Smits JAJ
• Early intervention may prevent the development of posttraumatic stress disorder: a randomized pilot civilian study with modified prolonged exposure.
  Biol Psychiatry Volume: 72 Page(s): 957 - 963
  12/01/2012 Authors: Rothbaum BO; Kearns MC; Price M; Malcoun E; Davis M; Ressler KJ; Lang D; Houry D
• A naturally derived cardiac extracellular matrix enhances cardiac progenitor cell behavior in vitro.
  Acta Biomater Volume: 8 Page(s): 4357 - 4364
  12/01/2012 Authors: French KM; Boopathy AV; DeQuach JA; Chingozha L; Lu H; Christman KL; Davis ME
• Characterization of superoxide dismutases in cardiac progenitor cells demonstrates a critical role for manganese superoxide dismutase.
  Stem Cells Dev Volume: 21 Page(s): 3136 - 3146
  11/20/2012 Authors: Seshadri G; Che PL; Boopathy AV; Davis ME
• The efficacy of vigorous-intensity exercise as an aid to smoking cessation in adults with elevated anxiety sensitivity: study protocol for a randomized controlled trial.
  Trials Volume: 13 Page(s): 207
  11/13/2012 Authors: Smits JAJ; Zvolensky MJ; Rosenfield D; Marcus BH; Church TS; Frierson GM; Powers MB; Otto MW; Davis ML; DeBoer LB
• Apolipoprotein e genotype-dependent paradoxical short-term effects of (56)fe irradiation on the brain.
  Int J Radiat Oncol Biol Phys Volume: 84 Page(s): 793 - 799
  11/01/2012 Authors: Haley GE; Villasana L; Dayger C; Davis MJ; Raber J
• Effect of bone marrow-derived extracellular matrix on cardiac function after ischemic injury.
  Biomaterials Volume: 33 Page(s): 7736 - 7745
  11/01/2012 Authors: Ravi S; Caves JM; Martinez AW; Xiao J; Wen J; Haller CA; Davis ME; Chaikof EL
• ApoE isoform-dependent deficits in extinction ofcontextual fear conditioning.
  Genes Brain Behav Volume: 11 Page(s): 806 - 812
  10/01/2012 Authors: Olsen RHJ; Agam M; Davis MJ; Raber J
• A metaplasticity-like mechanism supports the selection of fear memories: role of protein kinase a in the amygdala.
  J Neurosci Volume: 32 Page(s): 7843 - 7851
  06/06/2012 Authors: Parsons RG; Davis M
• Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review.
  Interface Focus Volume: 2 Page(s): 307 - 324
  06/06/2012 Authors: Liu J; Gray WD; Davis ME; Luo Y
• Effects of neonatal amygdala lesions on fear learning, conditioned inhibition, and extinction in adult macaques.
  Behav Neurosci Volume: 126 Page(s): 392 - 403
  06/01/2012 Authors: Kazama AM; Heuer E; Davis M; Bachevalier J
• The best of times, the worst of times for psychiatric disease.
  Nat Neurosci Volume: 15 Page(s): 811 - 812
  05/25/2012 Authors: Karayiorgou M; Flint J; Gogos JA; Malenka RC; Genetic and Neural Complexity in Psychiatry 2011 Working Group
• Rats with Low Acoustic Startle Have Increased Cocaine Self-Administration
  Volume: 71 Page(s): 303S - 303S
  04/15/2012 Authors: Wheeler MG; Davis M; Duncan EJ
• Measures of anxiety, sensorimotor function, and memory in male and female mGluR4/ mice.
  Behav Brain Res Volume: 229 Page(s): 21 - 28
  04/01/2012 Authors: Davis MJ; Haley T; Duvoisin RM; Raber J
• Impaired safety signal learning may be a biomarker of PTSD.
  Neuropharmacology Volume: 62 Page(s): 695 - 704
  02/01/2012 Authors: Jovanovic T; Kazama A; Bachevalier J; Davis M
• Age- and chamber-specific differences in oxidative stress after ischemic injury.
  Pediatr Cardiol Volume: 33 Page(s): 322 - 331
  02/01/2012 Authors: Cabigas EB; Ding G; Chen T; Saafir TB; Pendergrass KD; Wagner MB; Davis ME
• Dual delivery of hepatocyte and vascular endothelial growth factors via a protease-degradable hydrogel improves cardiac function in rats.
  PLoS One Volume: 7 Page(s): e50980
  01/01/2012 Authors: Salimath AS; Phelps EA; Boopathy AV; Che P-L; Brown M; Garca AJ; Davis ME
• Tools for translational neuroscience: PTSD is associated with heightened fear responses using acoustic startle but not skin conductance measures.
  Depress Anxiety Volume: 28 Page(s): 1058 - 1066
  12/21/2011 Authors: Glover EM; Phifer JE; Crain DF; Norrholm SD; Davis M; Bradley B; Ressler KJ; Jovanovic T
• N-acetylglucosamine conjugated to nanoparticles enhances myocyte uptake and improves delivery of a small molecule p38 inhibitor for post-infarct healing.
  J Cardiovasc Transl Res Volume: 4 Page(s): 631 - 643
  10/01/2011 Authors: Gray WD; Che P; Brown M; Ning X; Murthy N; Davis ME
• Effects of Fe-particle cranial radiation on hippocampus-dependent cognition depend on the salience of the environmental stimuli.
  Radiat Res Volume: 176 Page(s): 521 - 526
  10/01/2011 Authors: Raber J; Rosi S; Chakraborti A; Fishman K; Dayger C; Davis MJ; Villasana L; Fike JR
• Chronic exposure to anabolic androgenic steroids alters activity and synaptic function in neuroendocrine control regions of the female mouse.
  Neuropharmacology Volume: 61 Page(s): 653 - 664
  09/01/2011 Authors: Penatti CAA; Oberlander JG; Davis MC; Porter DM; Henderson LP
• Opposing roles of mGluR8 in measures of anxiety involving non-social and social challenges.
  Behav Brain Res Volume: 221 Page(s): 50 - 54
  08/01/2011 Authors: Duvoisin RM; Villasana L; Davis MJ; Winder DG; Raber J
• Phasic and sustained fear are pharmacologically dissociable in rats.
  Neuropsychopharmacology Volume: 36 Page(s): 1563 - 1574
  07/01/2011 Authors: Miles L; Davis M; Walker D
• Temporary disruption of fear-potentiated startle following PKM inhibition in the amygdala.
  Nat Neurosci Volume: 14 Page(s): 295 - 296
  03/01/2011 Authors: Parsons RG; Davis M
• Calcitonin gene-related peptide in the bed nucleus of the stria terminalis produces an anxiety-like pattern of behavior and increases neural activation in anxiety-related structures.
  J Neurosci Volume: 31 Page(s): 1802 - 1810
  02/02/2011 Authors: Sink KS; Walker DL; Yang Y; Davis M
• NMDA receptors and fear extinction: implications for cognitive behavioral therapy.
  Dialogues Clin Neurosci Volume: 13 Page(s): 463 - 474
  01/01/2011 Authors: Davis M
• Gone but not Forgotten.
  Front Behav Neurosci Volume: 5 Page(s): 51
  01/01/2011 Authors: Parsons RG; Davis M
• Temporal effects of catalase overexpression on healing after myocardial infarction.
  Circ Heart Fail Volume: 4 Page(s): 98 - 106
  01/01/2011 Authors: Pendergrass KD; Varghese ST; Maiellaro-Rafferty K; Brown ME; Taylor WR; Davis ME
• Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse.
  Psychoneuroendocrinology Volume: 35 Page(s): 1473 - 1485
  11/01/2010 Authors: Costine BA; Oberlander JG; Davis MC; Penatti CAA; Porter DM; Leaton RN; Henderson LP
• Differing effects of systemically administered rapamycin on consolidation and reconsolidation of context vs. cued fear memories.
  Learn Mem Volume: 17 Page(s): 577 - 581
  11/01/2010 Authors: Glover EM; Ressler KJ; Davis M
• Delivering regenerative cues to the heart: cardiac drug delivery by microspheres and peptide nanofibers.
  J Cardiovasc Transl Res Volume: 3 Page(s): 461 - 468
  10/01/2010 Authors: Sy JC; Davis ME
• D-cycloserine and exposure therapy
  Volume: 20 Page(s): S170 - S170
  08/01/2010 Authors: Rothbaum B; Davis M; Ressler K
• Fear potentiation is associated with hypothalamic-pituitary-adrenal axis function in PTSD.
  Psychoneuroendocrinology Volume: 35 Page(s): 846 - 857
  07/01/2010 Authors: Jovanovic T; Norrholm SD; Blanding NQ; Phifer JE; Weiss T; Davis M; Duncan E; Bradley B; Ressler K
• Surface functionalization of polyketal microparticles with nitrilotriacetic acid-nickel complexes for efficient protein capture and delivery.
  Biomaterials Volume: 31 Page(s): 4987 - 4994
  06/01/2010 Authors: Sy JC; Phelps EA; Garca AJ; Murthy N; Davis ME
• Altered GABAA receptor-mediated synaptic transmission disrupts the firing of gonadotropin-releasing hormone neurons in male mice under conditions that mimic steroid abuse.
  J Neurosci Volume: 30 Page(s): 6497 - 6506
  05/12/2010 Authors: Penatti CAA; Davis MC; Porter DM; Henderson LP
• Impaired fear inhibition is a biomarker of PTSD but not depression.
  Depress Anxiety Volume: 27 Page(s): 244 - 251
  03/01/2010 Authors: Jovanovic T; Norrholm SD; Blanding NQ; Davis M; Duncan E; Bradley B; Ressler KJ
• The delivery of superoxide dismutase encapsulated in polyketal microparticles to rat myocardium and protection from myocardial ischemia-reperfusion injury.
  Biomaterials Volume: 31 Page(s): 1372 - 1379
  02/01/2010 Authors: Seshadri G; Sy JC; Brown M; Dikalov S; Yang SC; Murthy N; Davis ME
• Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety.
  Neuropsychopharmacology Volume: 35 Page(s): 105 - 135
  01/01/2010 Authors: Davis M; Walker DL; Miles L; Grillon C
• Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses.
  Prog Neuropsychopharmacol Biol Psychiatry Volume: 33 Page(s): 1291 - 1308
  11/13/2009 Authors: Walker DL; Miles LA; Davis M
• Anxiolytic-like effects of the neurokinin 1 receptor antagonist GR-205171 in the elevated plus maze and contextual fear-potentiated startle model of anxiety in gerbils.
  Behav Pharmacol Volume: 20 Page(s): 584 - 595
  10/01/2009 Authors: Heldt SA; Davis M; Ratti E; Corsi M; Trist D; Ressler KJ
• Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction.
  Circulation Volume: 120 Page(s): 876 - 887
  09/08/2009 Authors: Padin-Iruegas ME; Misao Y; Davis ME; Segers VFM; Esposito G; Tokunou T; Urbanek K; Hosoda T; Rota M; Anversa P
• Effects of cocaine self-administration history under limited and extended access conditions on in vivo striatal dopamine neurochemistry and acoustic startle in rhesus monkeys.
  Psychopharmacology (Berl) Volume: 205 Page(s): 237 - 247
  08/01/2009 Authors: Kirkland Henry P; Davis M; Howell LL
• Posttraumatic stress disorder may be associated with impaired fear inhibition: relation to symptom severity.
  Psychiatry Res Volume: 167 Page(s): 151 - 160
  05/15/2009 Authors: Jovanovic T; Norrholm SD; Fennell JE; Keyes M; Fiallos AM; Myers KM; Davis M; Duncan EJ
• Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses.
  Neuropsychopharmacology Volume: 34 Page(s): 1533 - 1542
  05/01/2009 Authors: Walker D; Yang Y; Ratti E; Corsi M; Trist D; Davis M
• Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes.
  Mol Psychiatry Volume: 14 Page(s): 37 - 50
  01/01/2009 Authors: Keen-Rhinehart E; Michopoulos V; Toufexis DJ; Martin EI; Nair H; Ressler KJ; Davis M; Owens MJ; Nemeroff CB; Wilson ME
• Functional interactions between endocannabinoid and CCK neurotransmitter systems may be critical for extinction learning.
  Neuropsychopharmacology Volume: 34 Page(s): 509 - 521
  01/01/2009 Authors: Chhatwal JP; Gutman AR; Maguschak KA; Bowser ME; Yang Y; Davis M; Ressler KJ
• Effects of substance P in the amygdala, ventromedial hypothalamus, and periaqueductal gray on fear-potentiated startle.
  Neuropsychopharmacology Volume: 34 Page(s): 331 - 340
  01/01/2009 Authors: Zhao Z; Yang Y; Walker DL; Davis M
• Learning-dependent structural plasticity in the adult olfactory pathway.
  J Neurosci Volume: 28 Page(s): 13106 - 13111
  12/03/2008 Authors: Jones SV; Choi DC; Davis M; Ressler KJ
• The role of neuropeptide Y in the expression and extinction of fear-potentiated startle.
  J Neurosci Volume: 28 Page(s): 12682 - 12690
  11/26/2008 Authors: Gutman AR; Yang Y; Ressler KJ; Davis M
• Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction.
  Nat Mater Volume: 7 Page(s): 863 - 868
  11/01/2008 Authors: Sy JC; Seshadri G; Yang SC; Brown M; Oh T; Dikalov S; Murthy N; Davis ME
• Timing of extinction relative to acquisition: a parametric analysis of fear extinction in humans.
  Behav Neurosci Volume: 122 Page(s): 1016 - 1030
  10/01/2008 Authors: Norrholm SD; Vervliet B; Jovanovic T; Boshoven W; Myers KM; Davis M; Rothbaum B; Duncan EJ
• Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer.
  Brain Struct Funct Volume: 213 Page(s): 29 - 42
  09/01/2008 Authors: Walker DL; Davis M
• Engineering insulin-like growth factor-1 for local delivery.
  FASEB J Volume: 22 Page(s): 1886 - 1893
  06/01/2008 Authors: Tokunou T; Miller R; Patwari P; Davis ME; Segers VFM; Grodzinsky AJ; Lee RT
• It is time to take a stand for medical research and against terrorism targeting medical scientists.
  Biol Psychiatry Volume: 63 Page(s): 725 - 727
  04/15/2008 Authors: Krystal JH; Carter CS; Geschwind D; Manji HK; March JS; Nestler EJ; Zubieta J-K; Charney DS; Goldman D; Gur RE
• Amygdala infusions of an NR2B-selective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test.
  Learn Mem Volume: 15 Page(s): 67 - 74
  02/01/2008 Authors: Walker DL; Davis M
• Acoustic startle reflex in rhesus monkeys: a review.
  Rev Neurosci Volume: 19 Page(s): 171 - 185
  01/01/2008 Authors: Davis M; Antoniadis EA; Amaral DG; Winslow JT
• Differential regional expression of brain-derived neurotrophic factor following olfactory fear learning.
  Learn Mem Volume: 14 Page(s): 816 - 820
  12/01/2007 Authors: Jones SV; Stanek-Rattiner L; Davis M; Ressler KJ
• Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury.
  Nat Med Volume: 13 Page(s): 970 - 974
  08/01/2007 Authors: Hsieh PCH; Segers VFM; Davis ME; MacGillivray C; Gannon J; Molkentin JD; Robbins J; Lee RT
• Neural systems involved in fear and anxiety measured with fear-potentiated startle.
  Am Psychol Volume: 61 Page(s): 741 - 756
  11/01/2006 Authors: Davis M
• Contingency awareness and fear inhibition in a human fear-potentiated startle paradigm.
  Behav Neurosci Volume: 120 Page(s): 995 - 1004
  10/01/2006 Authors: Jovanovic T; Norrholm SD; Keyes M; Fiallos A; Jovanovic S; Myers KM; Davis M; Duncan EJ
• Combining pharmacotherapy with cognitive behavioral therapy: traditional and new approaches.
  J Trauma Stress Volume: 19 Page(s): 571 - 581
  10/01/2006 Authors: Davis M; Barad M; Otto M; Southwick S
• Effects of D-cycloserine on extinction: translation from preclinical to clinical work.
  Biol Psychiatry Volume: 60 Page(s): 369 - 375
  08/15/2006 Authors: Davis M; Ressler K; Rothbaum BO; Richardson R
• Amygdala BDNF signaling is required for consolidation but not encoding of extinction.
  Nat Neurosci Volume: 9 Page(s): 870 - 872
  07/01/2006 Authors: Chhatwal JP; Stanek-Rattiner L; Davis M; Ressler KJ
• Anatomically discrete functional effects of adenoviral clostridial light chain gene-based synaptic inhibition in the midbrain.
  Gene Ther Volume: 13 Page(s): 942 - 952
  06/01/2006 Authors: Zhao Z; Krishnaney A; Teng Q; Yang J; Garrity-Moses M; Liu JK; Venkiteswaran K; Subramanian T; Davis M; Boulis NM
• Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction.
  Proc Natl Acad Sci U S A Volume: 103 Page(s): 8155 - 8160
  05/23/2006 Authors: Davis ME; Hsieh PCH; Takahashi T; Song Q; Zhang S; Kamm RD; Grodzinsky AJ; Anversa P; Lee RT
• Pharmacological treatments that facilitate extinction of fear: relevance to psychotherapy.
  NeuroRx Volume: 3 Page(s): 82 - 96
  01/01/2006 Authors: Davis M; Myers KM; Chhatwal J; Ressler KJ
• Different mechanisms of fear extinction dependent on length of time since fear acquisition.
  Learn Mem Volume: 13 Page(s): 216 - 223
  01/01/2006 Authors: Myers KM; Ressler KJ; Davis M
• Conditioned fear extinction and reinstatement in a human fear-potentiated startle paradigm.
  Learn Mem Volume: 13 Page(s): 681 - 685
  01/01/2006 Authors: Norrholm SD; Jovanovic T; Vervliet B; Myers KM; Davis M; Rothbaum BO; Duncan EJ
• Emotion, motivation, and the brain: reflex foundations in animal and human research.
  Prog Brain Res Volume: 156 Page(s): 3 - 29
  01/01/2006 Authors: Lang PJ; Davis M
• Central oxytocin, vasopressin, and corticotropin-releasing factor receptor densities in the basal forebrain predict isolation potentiated startle in rats.
  J Neurosci Volume: 25 Page(s): 11479 - 11488
  12/07/2005 Authors: Nair HP; Gutman AR; Davis M; Young LJ
• Extinction training initiated shortly after trauma may reduce spontaneous recovery, renewal and reinstatement: Implications for exposure-based psychotherapy
  Volume: 30 Page(s): S72 - S72
  12/01/2005 Authors: Myers KM; Davis M
• Sex differences in hormonal modulation of anxiety measured with light-enhanced startle: possible role for arginine vasopressin in the male.
  J Neurosci Volume: 25 Page(s): 9010 - 9016
  09/28/2005 Authors: Toufexis D; Davis C; Hammond A; Davis M
• Translational approaches to extinction: Facilitation of extinction by NMDA receptor agonists
  Volume: 16 Page(s): S10 - S10
  09/01/2005 Authors: Davis M
• Brain-derived neurotrophic factor in amygdala-dependent learning.
  Neuroscientist Volume: 11 Page(s): 323 - 333
  08/01/2005 Authors: Rattiner LM; Davis M; Ressler KJ
• Memory of social defeat is facilitated by cAMP response element-binding protein overexpression in the amygdala.
  Behav Neurosci Volume: 119 Page(s): 1125 - 1130
  08/01/2005 Authors: Jasnow AM; Shi C; Israel JE; Davis M; Huhman KL
• Partial reversal of phencyclidine-induced impairment of prepulse inhibition by secretin.
  Biol Psychiatry Volume: 58 Page(s): 67 - 73
  07/01/2005 Authors: Myers KM; Goulet M; Rusche J; Boismenu R; Davis M
• Fear potentiation and fear inhibition in a human fear-potentiated startle paradigm.
  Biol Psychiatry Volume: 57 Page(s): 1559 - 1564
  06/15/2005 Authors: Jovanovic T; Keyes M; Fiallos A; Myers KM; Davis M; Duncan EJ
• Inhibition of fear is related to symptom severity in posttraumatic stress disorder
  Volume: 57 Page(s): 119S - 119S
  04/15/2005 Authors: Jovanovic T; Norrholm SD; Keyes M; Fiallos AM; Myers KM; Davis M; Duncan EJ
• Pharmacological characterization of the anxiolytic effects of the opiate compound buprenorphine
  Volume: 57 Page(s): 124S - 124S
  04/15/2005 Authors: Glover EM; Davis M
• Mechanism of extinction may differ depending on when extinction training is initiated: Possible erasure of fear shortly following acquisition (1 to 24 hrs) and formation of a parallel inhibitory memory trace at longer delays (24 to 72 hrs)
  Volume: 57 Page(s): 55S - 56S
  04/15/2005 Authors: Myers KM; Davis M
• Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory versus context fear conditioning and expression
  Volume: 57 Page(s): 178S - 178S
  04/15/2005 Authors: Walker DL; Paschall GY; Davis M
• Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear
  Volume: 57 Page(s): 113S - 113S
  04/15/2005 Authors: Chhatwal JP; Maguschak KA; Davis M; Ressler KJ
• Glutamate as a therapeutic target in fear and anxiety: Preclinical rationale and future clinical directions
  Volume: 57 Page(s): 74S - 74S
  04/15/2005 Authors: Davis M; Goddard AW; Shekhar A; Schoepp DD; Mathew SJ
• Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear.
  Neuropsychopharmacology Volume: 30 Page(s): 516 - 524
  03/01/2005 Authors: Chhatwal JP; Davis M; Maguschak KA; Ressler KJ
• Alterations in diurnal cortisol rhythm and acoustic startle response in nonhuman primates with adverse rearing.
  Biol Psychiatry Volume: 57 Page(s): 373 - 381
  02/15/2005 Authors: Snchez MM; Noble PM; Lyon CK; Plotsky PM; Davis M; Nemeroff CB; Winslow JT
• Olfactory-mediated fear conditioning in mice: simultaneous measurements of fear-potentiated startle and freezing.
  Behav Neurosci Volume: 119 Page(s): 329 - 335
  02/01/2005 Authors: Jones SV; Heldt SA; Davis M; Ressler KJ
• Regulation of gephyrin and GABAA receptor binding within the amygdala after fear acquisition and extinction.
  J Neurosci Volume: 25 Page(s): 502 - 506
  01/12/2005 Authors: Chhatwal JP; Myers KM; Ressler KJ; Davis M
• Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning and expression.
  Learn Mem Volume: 12 Page(s): 120 - 129
  01/01/2005 Authors: Walker DL; Paschall GY; Davis M
• The nucleus accumbens is not critically involved in mediating the effects of a safety signal on behavior.
  Neuropsychopharmacology Volume: 30 Page(s): 17 - 26
  01/01/2005 Authors: Josselyn SA; Falls WA; Gewirtz JC; Pistell P; Davis M
• Role of gonadal steroids in fear vs. anxiety
  Volume: 29 Page(s): S66 - S67
  12/01/2004 Authors: Davis M
• Adverse rearing alters hypothalamic-pituitary-adrenal axis function and startle response in developing non-human primates: Effects of sex and serotonin-transporter genotype
  Volume: 29 Page(s): S205 - S205
  12/01/2004 Authors: Sanchez MM; Lyon CK; Noble PL; McCormack KM; Crawford JL; Boudreau M; Higley JD; Nemeroff CB; Plotsky PM; Davis M
• Progesterone attenuates corticotropin-releasing factor-enhanced but not fear-potentiated startle via the activity of its neuroactive metabolite, allopregnanolone.
  J Neurosci Volume: 24 Page(s): 10280 - 10287
  11/10/2004 Authors: Toufexis DJ; Davis C; Hammond A; Davis M
• Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
  Arch Gen Psychiatry Volume: 61 Page(s): 1136 - 1144
  11/01/2004 Authors: Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
• Neural systems involved in fear, anxiety and extinction
  Volume: 39 Page(s): 182 - 182
  10/01/2004 Authors: Davis M
• Involvement of central amygdalar and bed nucleus of the stria terminalis corticotropin-releasing factor in behavioral responses to social defeat.
  Behav Neurosci Volume: 118 Page(s): 1052 - 1061
  10/01/2004 Authors: Jasnow AM; Davis M; Huhman KL
• Actin cytoskeleton organization and posttranscriptional regulation of endothelial nitric oxide synthase during cell growth.
  Circ Res Volume: 95 Page(s): 488 - 495
  09/03/2004 Authors: Searles CD; Ide L; Davis ME; Cai H; Weber M
• Effects of the beta-blocker propranolol on cued and contextual fear conditioning in humans.
  Psychopharmacology (Berl) Volume: 175 Page(s): 342 - 352
  09/01/2004 Authors: Grillon C; Cordova J; Morgan CA; Charney DS; Davis M
• The effect of estrogen and tamoxifen on slow-acquisition fear conditioning in female rats.
  Volume: 46 Page(s): 123 - 123
  06/01/2004 Authors: Toufexis DJ; Hammond AS; Davis M
• Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning.
  J Neurosci Volume: 24 Page(s): 4796 - 4806
  05/19/2004 Authors: Rattiner LM; Davis M; French CT; Ressler KJ
• VR exposure therapy for fear of heights
  Volume: 55 Page(s): 51S - 51S
  04/15/2004 Authors: Rothbaum BO; Davis M; Ressler K; Zimand E; Graap K; Tannenbaum L
• Secretin modulation of amygdala-directed sensory processing and the potential role in neuropsychiatric diseases
  Volume: 55 Page(s): 162S - 163S
  04/15/2004 Authors: Rusche J; Boismenu R; Davis M; Goulet M; Myers KM; Tay J
• Inhibition of fear in a human fear-potentiated startle paradigm
  Volume: 55 Page(s): 216S - 216S
  04/15/2004 Authors: Jovanovic T; Keyes M; Fiallos A; Myers KM; Davis M; Duncan EJ
• Are fear memories made and maintained by the same NMDA receptor-dependent mechanisms?
  Neuron Volume: 41 Page(s): 680 - 682
  03/04/2004 Authors: Walker DL; Davis M
• Shear stress regulates endothelial nitric-oxide synthase promoter activity through nuclear factor kappaB binding.
  J Biol Chem Volume: 279 Page(s): 163 - 168
  01/02/2004 Authors: Davis ME; Grumbach IM; Fukai T; Cutchins A; Harrison DG
• Differential regulation of brain-derived neurotrophic factor transcripts during the consolidation of fear learning.
  Learn Mem Volume: 11 Page(s): 727 - 731
  01/01/2004 Authors: Rattiner LM; Davis M; Ressler KJ
• 5-hydroxytryptamine1A-like receptor activation in the bed nucleus of the stria terminalis: electrophysiological and behavioral studies.
  Neuroscience Volume: 128 Page(s): 583 - 596
  01/01/2004 Authors: Levita L; Hammack SE; Mania I; Li X-Y; Davis M; Rainnie DG
• Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress.
  Am J Physiol Heart Circ Physiol Volume: 285 Page(s): H2290 - H2297
  12/01/2003 Authors: McNally JS; Davis ME; Giddens DP; Saha A; Hwang J; Dikalov S; Jo H; Harrison DG
• Applying learning principles to the treatment of post-trauma reactions.
  Ann N Y Acad Sci Volume: 1008 Page(s): 112 - 121
  12/01/2003 Authors: Rothbaum BO; Davis M
• Brain-derived neurotrophic factor in amygdala-dependent fear conditioned learning
  Volume: 13 Page(s): S427 - S427
  09/01/2003 Authors: Ressler K; Rattiner LS; Davis M
• Facilitation of fear extinction by NMDA agonists
  Volume: 13 Page(s): S172 - S173
  09/01/2003 Authors: Davis M
• Genetics of childhood disorders: L. Learning and memory, part 3: fear conditioning.
  J Am Acad Child Adolesc Psychiatry Volume: 42 Page(s): 612 - 615
  05/01/2003 Authors: Ressler K; Davis M
• Role of c-Src in regulation of endothelial nitric oxide synthase expression during exercise training.
  Am J Physiol Heart Circ Physiol Volume: 284 Page(s): H1449 - H1453
  04/01/2003 Authors: Davis ME; Cai H; McCann L; Fukai T; Harrison DG
• Role of the amygdala in fear extinction measured with potentiated startle.
  Ann N Y Acad Sci Volume: 985 Page(s): 218 - 232
  04/01/2003 Authors: Davis M; Walker DL; Myers KM
• Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety.
  Eur J Pharmacol Volume: 463 Page(s): 199 - 216
  02/28/2003 Authors: Walker DL; Toufexis DJ; Davis M
• Akt-dependent phosphorylation of serine 1179 and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase 1/2 cooperatively mediate activation of the endothelial nitric-oxide synthase by hydrogen peroxide.
  Mol Pharmacol Volume: 63 Page(s): 325 - 331
  02/01/2003 Authors: Cai H; Li Z; Davis ME; Kanner W; Harrison DG; Dudley SC
• Group II metabotropic glutamate receptors within the amygdala regulate fear as assessed with potentiated startle in rats.
  Behav Neurosci Volume: 116 Page(s): 1075 - 1083
  12/01/2002 Authors: Walker DL; Rattiner LM; Davis M
• The role of glutamate and gamma-aminobutyric acid in fear extinction: clinical implications for exposure therapy.
  Biol Psychiatry Volume: 52 Page(s): 998 - 1007
  11/15/2002 Authors: Davis M; Myers KM
• Quantifying fear potentiated startle using absolute versus proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety.
  Psychopharmacology (Berl) Volume: 164 Page(s): 318 - 328
  11/01/2002 Authors: Walker DL; Davis M
• Regulation of synaptic plasticity genes during consolidation of fear conditioning.
  J Neurosci Volume: 22 Page(s): 7892 - 7902
  09/15/2002 Authors: Ressler KJ; Paschall G; Zhou X-L; Davis M
• Relationship of enhanced norepinephrine activity during memory consolidation to enhanced long-term memory in humans.
  Am J Psychiatry Volume: 159 Page(s): 1420 - 1422
  08/01/2002 Authors: Southwick SM; Davis M; Horner B; Cahill L; Morgan CA; Gold PE; Bremner JD; Charney DC
• Role of NMDA receptors and MAP kinase in the amygdala in extinction of fear: clinical implications for exposure therapy.
  Eur J Neurosci Volume: 16 Page(s): 395 - 398
  08/01/2002 Authors: Davis M
• Rearing experience differentially affects somatic and cardiac startle responses in rhesus monkeys (Macaca mulatta).
  Behav Neurosci Volume: 116 Page(s): 378 - 386
  06/01/2002 Authors: Parr LA; Winslow JT; Davis M
• Acoustic startle, prepulse inhibition, and fear-potentiated startle measured in rhesus monkeys.
  Biol Psychiatry Volume: 51 Page(s): 859 - 866
  06/01/2002 Authors: Winslow JT; Parr LA; Davis M
• Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.
  J Neurosci Volume: 22 Page(s): 2343 - 2351
  03/15/2002 Authors: Walker DL; Ressler KJ; Lu K-T; Davis M
• The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction.
  Pharmacol Biochem Behav Volume: 71 Page(s): 379 - 392
  03/01/2002 Authors: Walker DL; Davis M
• Olfactory-mediated fear-potentiated startle.
  Behav Neurosci Volume: 116 Page(s): 4 - 12
  02/01/2002 Authors: Paschall GY; Davis M
• Light-enhanced startle: further pharmacological and behavioral characterization.
  Psychopharmacology (Berl) Volume: 159 Page(s): 304 - 310
  01/01/2002 Authors: Walker DL; Davis M
• Second-order olfactory-mediated fear-potentiated startle.
  Learn Mem Volume: 9 Page(s): 395 - 401
  01/01/2002 Authors: Paschall GY; Davis M
• Shear stress regulates endothelial nitric oxide synthase expression through c-Src by divergent signaling pathways.
  Circ Res Volume: 89 Page(s): 1073 - 1080
  11/23/2001 Authors: Davis ME; Cai H; Drummond GR; Harrison DG
• Future directions for epilepsy research.
  Neurology Volume: 57 Page(s): 1536 - 1542
  11/13/2001 Authors: Jacobs MP; Fischbach GD; Davis MR; Dichter MA; Dingledine R; Lowenstein DH; Morrell MJ; Noebels JL; Rogawski MA; Spencer SS
• Summary of a National Institute of Mental Health workshop: developing animal models of anxiety disorders.
  Psychopharmacology (Berl) Volume: 157 Page(s): 327 - 339
  10/01/2001 Authors: Shekhar A; McCann UD; Meaney MJ; Blanchard DC; Davis M; Frey KA; Liberzon I; Overall KL; Shear MK; Tecott LH
• Induction of endothelial NO synthase by hydrogen peroxide via a Ca(2+)/calmodulin-dependent protein kinase II/janus kinase 2-dependent pathway.
  Arterioscler Thromb Vasc Biol Volume: 21 Page(s): 1571 - 1576
  10/01/2001 Authors: Cai H; Davis ME; Drummond GR; Harrison DG
• Mitogen-activated protein kinase cascade in the basolateral nucleus of amygdala is involved in extinction of fear-potentiated startle.
  J Neurosci Volume: 21 Page(s): RC162
  08/15/2001 Authors: Lu KT; Walker DL; Davis M
• A double dissociation in the affective modulation of startle in humans: effects of unilateral temporal lobectomy.
  J Cogn Neurosci Volume: 13 Page(s): 721 - 729
  08/15/2001 Authors: Funayama ES; Grillon C; Davis M; Phelps EA
• Fear-potentiated startle in rats.
  Curr Protoc Neurosci Volume: Chapter 8 Page(s): Unit - 8.11A
  05/01/2001 Authors: Davis M
• Cracking down on caveolin: role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in modulating edothelial cell nitric oxide production.
  Circulation Volume: 103 Page(s): 2 - 4
  01/02/2001 Authors: Davis ME; Harrison DG
• The amygdala: vigilance and emotion.
  Mol Psychiatry Volume: 6 Page(s): 13 - 34
  01/01/2001 Authors: Davis M; Whalen PJ
• Involvement of NMDA receptors within the amygdala in short- versus long-term memory for fear conditioning as assessed with fear-potentiated startle.
  Behav Neurosci Volume: 114 Page(s): 1019 - 1033
  12/01/2000 Authors: Walker DL; Davis M
• Xv4-vrxv4: a new gene-for-gene interaction identified between Xanthomonas campestris pv. vesicatoria race T3 and wild tomato relative Lycopersicon pennellii.
  Mol Plant Microbe Interact Volume: 13 Page(s): 1346 - 1355
  12/01/2000 Authors: Astua-Monge G; Minsavage GV; Stall RE; Vallejos CE; Davis MJ; Jones JB
• Resistance of tomato and pepper to T3 strains of Xanthomonas campestris pv. vesicatoria is specified by a plant-inducible avirulence gene.
  Mol Plant Microbe Interact Volume: 13 Page(s): 911 - 921
  09/01/2000 Authors: Astua-Monge G; Minsavage GV; Stall RE; Davis MJ; Bonas U; Jones JB
• Differential regulation of vascular smooth muscle nuclear factor kappa-B by G alpha q-coupled and cytokine receptors.
  J Mol Cell Cardiol Volume: 32 Page(s): 391 - 403
  03/01/2000 Authors: Abbott KL; Robida AM; Davis ME; Pavlath GK; Camden JM; Turner JT; Murphy TJ
• Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide.
  Circ Res Volume: 86 Page(s): 347 - 354
  02/18/2000 Authors: Drummond GR; Cai H; Davis ME; Ramasamy S; Harrison DG
• The extended amygdala: are the central nucleus of the amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety?
  Ann N Y Acad Sci Volume: 877 Page(s): 281 - 291
  06/29/1999 Authors: Davis M; Shi C
• Are different parts of the extended amygdala involved in fear versus anxiety?
  Biol Psychiatry Volume: 44 Page(s): 1239 - 1247
  12/15/1998 Authors: Davis M
• Effects of experimental context and explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder.
  Biol Psychiatry Volume: 44 Page(s): 1027 - 1036
  11/15/1998 Authors: Grillon C; Morgan CA; Davis M; Southwick SM
• Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure.
  Proc Natl Acad Sci U S A Volume: 95 Page(s): 10140 - 10145
  08/18/1998 Authors: Adams JW; Sakata Y; Davis MG; Sah VP; Wang Y; Liggett SB; Chien KR; Brown JH; Dorn GW
• Lesions of the bed nucleus of the stria terminalis block sensitization of the acoustic startle reflex produced by repeated stress, but not fear-potentiated startle.
  Prog Neuropsychopharmacol Biol Psychiatry Volume: 22 Page(s): 625 - 648
  05/01/1998 Authors: Gewirtz JC; McNish KA; Davis M
• Rickettsial relative associated with papaya bunchy top disease.
  Curr Microbiol Volume: 36 Page(s): 80 - 84
  02/01/1998 Authors: Davis MJ; Ying Z; Brunner BR; Pantoja A; Ferwerda FH
• Application of Pavlovian higher-order conditioning to the analysis of the neural substrates of fear conditioning.
  Neuropharmacology Volume: 37 Page(s): 453 - 459
  01/01/1998 Authors: Gewirtz JC; Davis M
• Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear.
  J Neurosci Volume: 17 Page(s): 9375 - 9383
  12/01/1997 Authors: Walker DL; Davis M
• Opposing roles of the amygdala and dorsolateral periaqueductal gray in fear-potentiated startle.
  Neurosci Biobehav Rev Volume: 21 Page(s): 743 - 753
  11/01/1997 Authors: Walker DL; Cassella JV; Lee Y; De Lima TC; Davis M
• Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats.
  Biol Psychiatry Volume: 42 Page(s): 461 - 471
  09/15/1997 Authors: Walker DL; Davis M
• Darkness facilitates the acoustic startle reflex in humans.
  Biol Psychiatry Volume: 42 Page(s): 453 - 460
  09/15/1997 Authors: Grillon C; Pellowski M; Merikangas KR; Davis M
• Effects of stress and shock anticipation on prepulse inhibition of the startle reflex.
  Psychophysiology Volume: 34 Page(s): 511 - 517
  09/01/1997 Authors: Grillon C; Davis M
• Involvement of the dorsal periaqueductal gray in the loss of fear-potentiated startle accompanying high footshock training.
  Behav Neurosci Volume: 111 Page(s): 692 - 702
  08/01/1997 Authors: Walker DL; Davis M
• Normal conditioned inhibition and extinction of freezing and fear-potentiated startle following electrolytic lesions of medical prefrontal cortex in rats.
  Behav Neurosci Volume: 111 Page(s): 712 - 726
  08/01/1997 Authors: Gewirtz JC; Falls WA; Davis M
• Roles of the amygdala and bed nucleus of the stria terminalis in fear and anxiety measured with the acoustic startle reflex. Possible relevance to PTSD.
  Ann N Y Acad Sci Volume: 821 Page(s): 305 - 331
  06/21/1997 Authors: Davis M; Walker DL; Lee Y
• Evidence of acoustic startle hyperreflexia in recently detoxified early onset male alcoholics: modulation by yohimbine and m-chlorophenylpiperazine (mCPP).
  Psychopharmacology (Berl) Volume: 131 Page(s): 207 - 215
  06/01/1997 Authors: Krystal JH; Webb E; Grillon C; Cooney N; Casal L; Morgan CA; Southwick SM; Davis M; Charney DS
• Structural determinants for agonist binding affinity to thromboxane/prostaglandin endoperoxide (TP) receptors. Analysis of chimeric rat/human TP receptors.
  J Biol Chem Volume: 272 Page(s): 12399 - 12405
  05/09/1997 Authors: Dorn GW; Davis MG; D'Angelo DD
• Intracrine and autocrine effects of basic fibroblast growth factor in vascular smooth muscle cells.
  J Mol Cell Cardiol Volume: 29 Page(s): 1061 - 1072
  04/01/1997 Authors: Davis MG; Zhou M; Ali S; Coffin JD; Doetschman T; Dorn GW
• Olfactory bulbectomy enhances sensitization of the acoustic startle reflex produced by acute or repeated stress.
  Behav Neurosci Volume: 111 Page(s): 80 - 91
  02/01/1997 Authors: McNish KA; Davis M
• Neurobiology of fear responses: the role of the amygdala.
  J Neuropsychiatry Clin Neurosci Volume: 9 Page(s): 382 - 402
  01/01/1997 Authors: Davis M
• Novel role for Sp1 in phorbol ester enhancement of human platelet thromboxane receptor gene expression.
  J Biol Chem Volume: 271 Page(s): 19696 - 19704
  08/16/1996 Authors: D'Angelo DD; Oliver BG; Davis MG; McCluskey TS; Dorn GW
• Lack of a temporal gradient of retrograde amnesia following NMDA-induced lesions of the basolateral amygdala assessed with the fear-potentiated startle paradigm.
  Behav Neurosci Volume: 110 Page(s): 836 - 839
  08/01/1996 Authors: Lee Y; Walker D; Davis M
• The role of the cytoskeleton in left ventricular pressure overload hypertrophy and failure.
  J Mol Cell Cardiol Volume: 28 Page(s): 1435 - 1443
  07/01/1996 Authors: Collins JF; Pawloski-Dahm C; Davis MG; Ball N; Dorn GW; Walsh RA
• Mutagenic analysis of platelet thromboxane receptor cysteines. Roles in ligand binding and receptor-effector coupling.
  J Biol Chem Volume: 271 Page(s): 6233 - 6240
  03/15/1996 Authors: D'Angelo DD; Eubank JJ; Davis MG; Dorn GW
• Fear-potentiated startle in posttraumatic stress disorder.
  Biol Psychiatry Volume: 38 Page(s): 378 - 385
  09/15/1995 Authors: Morgan CA; Grillon C; Southwick SM; Davis M; Charney DS
• Characterization of 5' end of human thromboxane receptor gene. Organizational analysis and mapping of protein kinase C--responsive elements regulating expression in platelets.
  Circ Res Volume: 77 Page(s): 466 - 474
  09/01/1995 Authors: D'Angelo DD; Davis MG; Houser WA; Eubank JJ; Ritchie ME; Dorn GW
• Tyrosine kinase inhibition prevents deformation-stimulated vascular smooth muscle growth.
  Hypertension Volume: 24 Page(s): 706 - 713
  12/01/1994 Authors: Davis MG; Ali S; Leikauf GD; Dorn GW
• Cloning and pharmacologic characterization of a thromboxane A2 receptor from K562 (human chronic myelogenous leukemia) cells.
  J Pharmacol Exp Ther Volume: 271 Page(s): 1034 - 1041
  11/01/1994 Authors: D'Angelo DD; Davis MG; Ali S; Dorn GW
• Dissociation of vasoconstrictor-stimulated basic fibroblast growth factor expression from hypertrophic growth in cultured vascular smooth muscle cells. Relevant roles of protein kinase C.
  Circ Res Volume: 75 Page(s): 836 - 843
  11/01/1994 Authors: Ali S; Becker MW; Davis MG; Dorn GW
• Gene expression during phorbol ester-induced differentiation of cultured human megakaryoblastic cells.
  Am J Physiol Volume: 266 Page(s): C1231 - C1239
  05/01/1994 Authors: Dorn GW; Davis MG; D'Angelo DD
• Neurotransmission in the rat amygdala related to fear and anxiety.
  Trends Neurosci Volume: 17 Page(s): 208 - 214
  05/01/1994 Authors: Davis M; Rainnie D; Cassell M
• Baseline and fear-potentiated startle in panic disorder patients.
  Biol Psychiatry Volume: 35 Page(s): 431 - 439
  04/01/1994 Authors: Grillon C; Ameli R; Goddard A; Woods SW; Davis M
• Thromboxane A2 stimulates vascular smooth muscle hypertrophy by up-regulating the synthesis and release of endogenous basic fibroblast growth factor.
  J Biol Chem Volume: 268 Page(s): 17397 - 17403
  08/15/1993 Authors: Ali S; Davis MG; Becker MW; Dorn GW
• Psychobiologic mechanisms of posttraumatic stress disorder.
  Arch Gen Psychiatry Volume: 50 Page(s): 295 - 305
  04/01/1993 Authors: Charney DS; Deutch AY; Krystal JH; Southwick SM; Davis M
• Treating patients with infectious diseases: an essay in the ethics of dentistry.
  Prof Ethics Volume: 2 Page(s): 51 - 65
  01/01/1993 Authors: Davis M
• Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle.
  J Biol Chem Volume: 267 Page(s): 24897 - 24905
  12/05/1992 Authors: Dorn GW; Becker MW; Davis MG
• Differential megakaryocytic desensitization to platelet agonists.
  Am J Physiol Volume: 263 Page(s): C864 - C872
  10/01/1992 Authors: Dorn GW; Davis MG
• Thrombin, but not thromboxane, stimulates megakaryocytic differentiation in human megakaryoblastic leukemia cells.
  J Pharmacol Exp Ther Volume: 262 Page(s): 1242 - 1247
  09/01/1992 Authors: Dorn GW; Davis MG
• Intra-amygdala infusion of the N-methyl-D-aspartate receptor antagonist AP5 blocks acquisition but not expression of fear-potentiated startle to an auditory conditioned stimulus.
  Behav Neurosci Volume: 106 Page(s): 569 - 574
  06/01/1992 Authors: Campeau S; Miserendino MJ; Davis M
• N-methyl-D-aspartate lesions of the lateral and basolateral nuclei of the amygdala block fear-potentiated startle and shock sensitization of startle.
  Behav Neurosci Volume: 106 Page(s): 72 - 80
  02/01/1992 Authors: Sananes CB; Davis M
• Codes of ethics, professions, and conflict of interest: a case study of an emerging profession, clinical engineering.
  Prof Ethics Volume: 1 Page(s): 179 - 195
  01/01/1992 Authors: Davis M
• Efferent pathway of the amygdala involved in conditioned fear as measured with the fear-potentiated startle paradigm.
  Behav Neurosci Volume: 105 Page(s): 826 - 842
  12/01/1991 Authors: Hitchcock JM; Davis M
• A direct projection from the central nucleus of the amygdala to the acoustic startle pathway: anterograde and retrograde tracing studies.
  Behav Neurosci Volume: 105 Page(s): 817 - 825
  12/01/1991 Authors: Rosen JB; Hitchcock JM; Sananes CB; Miserendino MJ; Davis M
• Induction of the c-fos proto-oncogene in rat amygdala during unconditioned and conditioned fear.
  Brain Res Volume: 565 Page(s): 349 - 352
  11/29/1991 Authors: Campeau S; Hayward MD; Hope BT; Rosen JB; Nestler EJ; Davis M
• Fear-potentiated startle in humans: effects of anticipatory anxiety on the acoustic blink reflex.
  Psychophysiology Volume: 28 Page(s): 588 - 595
  09/01/1991 Authors: Grillon C; Ameli R; Woods SW; Merikangas K; Davis M
• Blockade of the spinal excitatory effect of cAMP on the startle reflex by intrathecal administration of the isoquinoline sulfonamide H-8: comparison to the protein kinase C inhibitor H-7.
  Brain Res Volume: 525 Page(s): 198 - 204
  08/20/1990 Authors: Boulis NM; Davis M
• Differential blockade of early and late components of acoustic startle following intrathecal infusion of 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) or D,L-2-amino-5-phosphonovaleric acid (AP-5).
  Brain Res Volume: 520 Page(s): 240 - 246
  06/18/1990 Authors: Boulis NM; Kehne JH; Miserendino MJ; Davis M
• Footshock-induced sensitization of electrically elicited startle reflexes.
  Behav Neurosci Volume: 103 Page(s): 504 - 508
  06/01/1989 Authors: Boulis NM; Davis M
• Temporal characteristics of enhancement of startle by stimulation of the amygdala.
  Physiol Behav Volume: 44 Page(s): 117 - 123
  01/01/1988 Authors: Rosen JB; Davis M
• Apomorphine, d-amphetamine, strychnine and yohimbine do not alter prepulse inhibition of the acoustic startle reflex.
  Psychopharmacology (Berl) Volume: 95 Page(s): 151 - 156
  01/01/1988 Authors: Davis M
• Fear-potentiated startle using an auditory conditioned stimulus: effect of lesions of the amygdala.
  Physiol Behav Volume: 39 Page(s): 403 - 408
  01/01/1987 Authors: Hitchcock JM; Davis M
• Mescaline: excitatory effects on acoustic startle are blocked by serotonin2 antagonists.
  Psychopharmacology (Berl) Volume: 93 Page(s): 286 - 291
  01/01/1987 Authors: Davis M
• Pharmacological and anatomical analysis of fear conditioning using the fear-potentiated startle paradigm.
  Behav Neurosci Volume: 100 Page(s): 814 - 824
  12/01/1986 Authors: Davis M
• Lesions of the amygdala, but not of the cerebellum or red nucleus, block conditioned fear as measured with the potentiated startle paradigm.
  Behav Neurosci Volume: 100 Page(s): 11 - 22
  02/01/1986 Authors: Hitchcock J; Davis M
• Associative learning modifies startle reflexes at the lateral lemniscus.
  Behav Neurosci Volume: 99 Page(s): 191 - 199
  04/01/1985 Authors: Berg WK; Davis M
• Diazepam blocks fear-enhanced startle elicited electrically from the brainstem.
  Physiol Behav Volume: 32 Page(s): 333 - 336
  02/01/1984 Authors: Berg WK; Davis M
• Habituation and sensitization of startle reflexes elicited electrically from the brainstem.
  Science Volume: 218 Page(s): 688 - 690
  11/12/1982 Authors: Davis M; Parisi T; Gendelman DS; Tischler M; Kehne JH
• Pierce's disease of grapevines: isolation of the causal bacterium.
  Science Volume: 199 Page(s): 75 - 77
  01/06/1978 Authors: Davis MJ; Purcell AH; Thomson SV
• Mental retardation, self-mutilation and hyperuricemia in females.
  Trans Am Neurol Assoc Volume: 93 Page(s): 187 - 188
  01/01/1968 Authors: Bazelon M; Stevens H; Davis M; Seegmiller JE; Green M
• A comparison of acetophenetidin and acetaminophen. I. Analgesic effects in postpartum patients.
  J Pharmacol Exp Ther Volume: 155 Page(s): 296 - 300
  02/01/1967 Authors: Lasagna L; Davis M; Pearson JW